Skip to content
Friday, August 15, 2025
  • Home
  • BCS News
    • Latest from BCS
    • BCS Editorials
    • Obituaries
    • Editors
  • COVID-19
  • BCS Home
Image of Heart shaped leaves on a plant for In Memory
News

Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve

CardioNewsUK 20 November 2020 Atrial FibrillationCardiologyResearch

Important data from Brazil demonstrating the safety and non inferiority of DOAC therapy in biological mitral valves and atrial fibrillation. This study makes a significant contribution to understand the ‘valvular’ AF story.

Post navigation

Previous Previous post: N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
Next Next post: CaReMe Heart Failure in Adults: Diagnosis & Management Algorithm

Video

https://youtu.be/jpDhCKcM7ak

RSS Heart Journal

  • Terminal renal failure as a contributor to high-sensitivity cardiac troponin T elevations: insights from patients undergoing renal transplantation
  • Perceived health, psychological distress and quality of life in 8415 adults with congenital heart disease from 32 countries
  • Determining kidney function-specific thresholds for N-terminal pro-B-type natriuretic peptide in heart failure risk prediction among patients with chronic kidney disease: a multicentre, observational, cohort study
  • Inflammation in coronary atherosclerosis: diagnosis and treatment
  • Catheter ablation versus medical rate control for persistent atrial fibrillation in older heart failure patients with reduced ejection fraction

RSS AHA Journal Feed

  • Cardiovascular Health Effects and Synthetic Cooling Agents in E‐Cigarettes Labeled as “Clear” Marketed in Massachusetts After the Tobacco Product Flavoring Ban
  • Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Stage 4 Cardiovascular–Kidney–Metabolic Syndrome: A Propensity Score–Matched Study
  • Twenty‐Four–Month Outcomes of Intravascular Ultrasound‐Guided Drug‐Coated Balloon Angioplasty for Femoropopliteal Artery Disease
  • Cognitive Assessments in Randomized Controlled Trials of Acute or Secondary Prevention Stroke Treatments 2011 to 2024: A Scoping Review
  • Atrial Natriuretic Peptide at Discharge as a Predictive Marker for Early Rehospitalization in Patients With Heart Failure With Preserved Ejection Fraction
UK Cardiology News |
British Cardiovascular Society
✕
BCS Heartbeat

FREE
VIEW